Utrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation

Launched by UMC UTRECHT · Jan 10, 2020

Keywords

ClinConnect Summary

This clinical trial, called the Utrecht Prostate Cohort, is focused on studying new treatments for prostate cancer, which is the most common cancer among men. The goal is to create a large group of men who have recently been diagnosed with prostate cancer. This group will help researchers evaluate the safety and effectiveness of new treatment options while also looking at how these treatments impact the quality of life of the patients. By gathering long-term data, the trial aims to improve understanding of how different therapies work and how they can be better tailored to meet patients' needs.

To participate in this trial, you need to be a man aged 18 or older who has just been diagnosed with prostate cancer and is being referred for treatment. This could be radiation therapy, surgery, or a monitoring approach known as "watchful waiting." Participants will be asked to provide consent to use their medical data and to complete questionnaires about their health and experiences. The study is currently recruiting participants, and it offers an opportunity to contribute to important research that may lead to better treatment options for prostate cancer in the future.

Gender

MALE

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 18 years.
• • Patients with newly diagnosed histologically proven prostate cancer, referred for radiation treatment to the Radiotherapy Department of the UMC Utrecht or for prostatectomy, watchful waiting or active surveillance to the Urology Department of St. Antonius hospital or the Urology Department of the UMC Utrecht.
• • Informed consent - at least - for use of routinely collected clinical data and to fill out questionnaires.
• Exclusion Criteria:
• • Mentally incompetent patients.
• • Inability to understand the Dutch language.